Ovarian carcinomas that have a distinctive natural history with early
dissemination are particularly problematic. The aim of this immunohist
ochemical study was to assess whether the nm23H1 gene product, which i
n some tumors shows inverse association with metastatic potential, cou
ld serve as a prognostic makrer for ovarian carcinomas. The study, bas
ed on 73 benign and 54 malignant ovarian tumors, showed clear differen
ces in the frequency of nm23-H1-positive samples, the intensity of sta
ining and the histological localization of this protein. Differences w
ere observed between normal ovary samples and benign lesions as well a
s between benign tumors and ovarian carcinomas and were highly signifi
cant. Furthermore, carcinomas that had detectable metastasis at the ti
me of surgery were negative for nm23-H1 protein more frequently than t
hose that did not. Although this is a prospective study in which colle
ction of clinical data is ongoing, the results strongly suggest that n
m23-H1 may serve as a potentially valuable marker for ovarian tumors.